Valuation: BrainsWay Ltd.

Market Cap 613M 531M 496M 453M 855M 58.48B 868M 5.82B 2.28B 29.26B 2.3B 2.25B 97.44B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 613M 531M 496M 453M 855M 58.48B 868M 5.82B 2.28B 29.26B 2.3B 2.25B 97.44B EV / Sales 2026 *
9.06x
EV / Sales 2027 * 7.42x
Free-Float
90.49%
Yield 2026 *
-
Yield 2027 * -
1 day-1.16%
1 week-3.10%
Current month+0.59%
1 month+1.73%
3 months-10.77%
6 months+31.22%
Current year+61.09%
1 week 14.96
Extreme 14.96
16.5
1 month 13.86
Extreme 13.86
17.29
Current year 9.5
Extreme 9.5
17.35
1 year 5.9
Extreme 5.9
17.35
3 years 1.36
Extreme 1.355
17.35
5 years 0.69
Extreme 0.69
17.35
10 years 0.69
Extreme 0.69
17.35
Manager TitleAgeSince
Chief Executive Officer 54 2023-02-12
Chief Tech/Sci/R&D Officer 56 2006-04-30
Director of Finance/CFO 50 2023-05-22
Director TitleAgeSince
Chairman 74 2002-12-31
Director/Board Member 70 2006-10-31
Director/Board Member 56 2019-06-16
Change 5-day change 1-year change 3-year change Capi.($)
-1.16%-3.10% - - 631M
+0.96%+4.47%+30.16%+9.58% 220B
+2.25%+6.01%+4.39%-18.65% 144B
+3.85%+4.79%-16.32%+29.12% 134B
+2.33%+4.19%-51.08%-0.79% 71.46B
+2.57%+3.61%+17.46%+17.57% 51.71B
-0.86%+0.15%-15.64%-18.16% 50.84B
+1.88%+6.38%+29.75%+16.51% 41.23B
+1.21%+9.88%+46.43%+42.33% 39.95B
+1.63%+4.60%+1.31%+0.89% 32.42B
Average +1.47%+4.56%+5.16%+8.71% 87.22B
Weighted average by Cap. +1.89%+5.45%+5.93%+7.19%

Financials

2026 *2027 *
Net sales 67.65M 58.56M 54.74M 50.03M 94.28M 6.45B 95.75M 642M 252M 3.23B 254M 248M 10.75B 82.64M 71.55M 66.87M 61.12M 115M 7.88B 117M 784M 308M 3.94B 310M 304M 13.13B
Net income 12.42M 10.75M 10.05M 9.19M 17.31M 1.18B 17.58M 118M 46.25M 593M 46.64M 45.62M 1.97B 19.74M 17.09M 15.97M 14.6M 27.5M 1.88B 27.93M 187M 73.48M 942M 74.11M 72.49M 3.14B
Net Debt - -
Logo BrainsWay Ltd.
Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
Employees
129
Date Price Change Volume
26-08-10 US$15.32 -1.16% 55,214
26-08-07 US$15.50 -0.96% 86,722
26-08-06 US$15.65 +4.26% 120,574
26-08-05 US$15.01 -5.00% 83,590
26-08-04 US$15.80 -0.06% 140,945

Quarterly revenue - Rate of surprise